Infinity Pharmaceuticals appoints director
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Michael Kauffman was appointed an independent director of Infinity Pharmaceuticals Inc.'s board.
Kauffman was also appointed to the board's governance committee and research and development committee.
Further, José Baselga opted to retire from the company's board at the end of his current term, which expires at Infinity's 2017 annual meeting of stockholders.
